References
- 1. Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: implication for translational therapeutic. Cancer. 2007; 110(9): 1911-1928.
- 2. Chung YC, Chaen YL, Hsu CP. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. Anti-Cancer Res. 2006; 26(5B): 3905-1911.
- 3. Jenny NS, Tracy RP, Ogg MS, Lung Le A, Kuller LH, et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphisms are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002; 22(12): 2066-2071.
- 4. Gangwar R, Mittal B, Mittal RD. Association with interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer. Int J Biol Marker. 2009; 24(1): 11-16.
- 5. Pola R, Flex A, Gaetani E, Lago AD, Geradino L, Pola P, et al. The -174 polymorphism of the interleukin-6 gene is associated with Alzheimer’s disease in an Italian population. Neuroreport. 2002; 13(13): 1645-1647.
- 6. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol. 2005; 23: 1-21.
- 7. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel poly-morphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7): 1369-1376.
- 8. Ikeda U, Ikeda M, Oohara T, Ooguchi A, Kamitani T, Tsuruya Y, et al. Interleukin-6 stimulates growth of vascular smooth muscle in a PDGFdependent manner. Am J Physiol. 1991; 260(5 Pt 2): H1713-H1717.
- 9. Meenagh A, Fionnuala W, Owen AR, Patterson C, Gorodezsky C, Hammond M, et al. Frequency of cytokine polymorphism in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol. 2002; 63(11): 1055-1061.
- 10. Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, et al. Allele frequencies of TNF-a, IL-6, IL-10 and IFN-g in an Italian Caucasian population. Eur J Immunogenet. 2002; 29(3): 237-240.
- 11. Kesarwani P, Ahirwar D, Singh R, Manchanda PL, Mittal RD. Do IL-4 intron 3 VNTR and IL-6 (-174) G/C variants reflect ethnic variation? A comparative study between the global and North Indian populations. Asian Pac J Cancer Prev. 2008; 9(1):76-80.
- 12. Ognjanovic S, Yamamoto J, Saltzman B, Franke A, Ognjanovic M, Yokochi L, et al. Serum CRP and IL-6, genetic variants and colorectal adenoma in a multiethnic population. Cancer Causes Control. 2010; 21(7): 1131-1138.
- 13. Riikola A, Sipilä K, Kähonen M, Jula A, Nieminen MS, Moilanen L, et al. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health Survey 2000. Atherosclerosis. 2007; 207(2): 466-470.
- 14. Capurso C, Solfrizzi V, D’Introno A, Colacicco AM, Capurso SA, Capurso A, et al. Interleukin-6 -174 G/C promoter gene polymorphism and sporadic Alzheimer disease: geographic allele and genotypic variation in Europe. Exp Gerontol. 2004; 39(10): 1567-1573.
- 15. Donn RP, Barret JH, Farhan A, Stopford A, Pepper L, Shelley E, et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group. Arthritis Rheum. 2001; 44(4): 802-810.
- 16. Pan M, Gao SP, Jiang MH, Gua J, Zheng JG, Zhu JH. Interluekin-6 promoter polymorphism in normal Han Chinese population: frequency and effects on inflammatory markers. J Invest Med. 2011;59(2):272-276.
- 17. Hirschman C. The meaning and measurement of ethnicity in Malaysia: an analysis of census classification. J Asian Stud. 1987; 46(3): 555-582.
- 18. Chua KH, Kee BP, Tan SY, Lian LH. Interleukin-6 promoter polymorphisms (-174G/C) in Malaysian patients with systemic lupus erythematosus. Braz J Med Biol Res. 2009; 42(6): 551-555.
- 19. Tong Y, Lu Z, Zhang Y, Ye J, Zhan F, Hou S, etal. Comparison of the G-174C polymorphism of interleu-kin (IL)-6 in different countries. African J Biotechnol. 2012; 11(28): 7166-769.
- 20. Park BL, Lee HS, Kim YJ, Kim JY, Jung JH, Kim LH, et al. Association between interleukin 6 promoter variation and chronic hepatitis B progression. Exp Mol Med. 2003; 35(2): 76-82.
- 21. Visentainer JEL, Sell AM, da Silva GC, Cavichioli ADG, Franceschi DSA, Liebert SR, etal. TNF, IFNG, IL-6, IL-10 and TGFB1 gene polymorphisms in South and Southeast Brazil. Int J Immunogenet. 2008; 35(4-5): 287-293.
- 22. Ryu JH, Kim SJ. Interleukin-6 -634C/G and -174 G/C polymorphisms in Korean patients undergoing hemodialysis. Korean J Int Med. 2012; 27(3): 327-337.
- 23. Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, et al. Polymorphism of IL-1B, IL-1 RN, IL-2, IL-4, IL-6, IL-10 and IFN-g genes in the Korean population. Hum Immunol. 2003; 64(10): 979-989.
- 24. Bhanoori M, Babu KA, Deenadayal M, Kennedy S, Shivaji S.. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women. J Soc Gynecol Investig. 2005; 12(5): 365-369.
- 25. Liu RY, Song X, Chen P, Lei Z, Miao J, Yi N, et al. Association between IL 6 -174G/C and cancer; a meta-analysis of 105,482 individuals. Exp Ther Med. 2012; 3(4): 655-664.
- 26. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, et al. IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Bio. Rep. 2011; 38(4): 2589-2596.
- 27. Yin YW, Hu AM, Sun QQ, Liu HL, Wong Q, Zeng YH, et al. Associations between IL-6 gene -174G/C polymorphism and the risk of coronary heart disease; a meta-analysis of 20 studies including 9619 cases and 10,919 controls. Gene. 2012; 53(1): 25-30.
- 28. Lee J, Heng D, Chia KS, Chew SK, Tan BY, Hughes K. Risk factors and incidence of coronary artery disease in Chinese, Malay and Asian Indians males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol. 2001; 30(5): 983-988.
- 29. Heng DM, Lee J, Chew SK, Tan BY, Hughes K, Chia KS. Incidence of ischaemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore cardiovascular cohort study. Ann Acad Med Singapore. 2000; 29(2): 231-236.
- 30. Amin AA, Nathan S, Evans AT, Attanasio S, Mukhopadhyay E, Metha V, et al. The effect of ethnicity on the relationship between premature coronary artery disease and traditional cardiac risk factors among uninsured young adults. Prev Cardiol. 2009; 12(3): 128-135.